docetaxel anhydrous has been researched along with pyruvic acid in 1 studies
Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (pyruvic acid) | Trials (pyruvic acid) | Recent Studies (post-2010) (pyruvic acid) |
---|---|---|---|---|---|
12,110 | 3,216 | 6,920 | 8,310 | 169 | 2,501 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Aggarwal, R; Bok, RA; Carvajal, L; Chen, HY; Gordon, JW; Kurhanewicz, J; Larson, PEZ; Lee, P; Ohliger, MA; Slater, JB; Small, EJ; van Criekinge, M; Vigneron, DB; Zhu, Z | 1 |
1 other study(ies) available for docetaxel anhydrous and pyruvic acid
Article | Year |
---|---|
Hyperpolarized
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carbon Isotopes; Carboplatin; Docetaxel; Feasibility Studies; Follow-Up Studies; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pilot Projects; Prognosis; Prostatic Neoplasms; Pyruvic Acid; Survival Rate | 2020 |